News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Filters
MindMed Expands Psychedelic Microdosing Division, Adds Groundbreaking Study Evaluating LSD Microdosing Through Next-Gen Digital Clinical Markers
Mind Medicine (MindMed)
NeonMind Engages Dr. C. Laird Birmingham to Develop Protocols for Phase 2 Clinical Trial Using Psilocybin to Treat Obesity
NeonMind Biosciences Inc.
NeonMind Announces Grants Pursuant to Stock Option Plan
NeonMind Biosciences Inc.
Core One Labs Announces Breakthrough in Solving Psilocybin Dosing Problems by Introducing Biosynthetic Psilocybin to its Patented Thinstrip Delivery Method
Core One Labs Inc.
Entheon Biomedical Engages World Renowned Media Personality DJ Skee, AKA Scott Keeney, as Media Advisor
Entheon Biomedical
Champignon Brands Announces New CFO and New General Counsel
Braxia Scientific Corp.
Mydecine Innovations Group Appoints Gordon Neal to Board of Directors and Dean Ditto as Chief Financial Officer
Mydecine Innovations Group
Legal Psychedelic Therapy Comes to Alberta With Ground-Breaking Health Canada Decision
No items found.
Review of Bipolar Disorders Confirms Early Diagnosis and Treatment Can Improve Patient Quality of Life
Braxia Scientific Corp.
Nethaji Gallage | CEO & Co-Founder, Octarine Bio
Octarine Bio
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.